Lipid nanoparticles

Lipid nanoparticles (LNPs) are the most clinically advanced delivery system for RNA-based drugs but have predominantly been investigated for intravenous...

The purpose of the study was to develop a novel, directly compressible, co-processed excipient capable of providing a controlled-release drug...

Introduction: Solid lipid nanoparticles (SLNs) are considered a promising system in enhancing the oral bioavailability of poorly water-soluble drugs; owing to...

21. August 2017 Solid lipid nanoparticles (SLN) containing rifabutin (RFB), with pulmonary administration purposes, were developed through a technique that...

Abstract Associating protein with nanoparticles is an interesting strategy to improve their bioavailability and biological activity. Solid lipid nanoparticles (SLN)...

  Abstract Solid lipid microparticles (SLM) were produced by produced by a two-step process that, firstly, involved the emulsification of...

08. October 2016 Abstract The number of topical fungal infections is growing, mostly owing to immunosuppressive therapy. Several topical fungal...

21. October 2015 Nowadays exploration of novel lipid-based formulations is akin to a magnet for researchers worldwide for improving the...